loratadine has been researched along with Metabolic Syndrome in 1 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasheva, OY | 1 |
| Tsoy Nizamutdinova, I | 1 |
| Hargrove, L | 1 |
| Gobbell, C | 1 |
| Troyanova-Wood, M | 1 |
| Alpini, SF | 1 |
| Pal, S | 1 |
| Du, C | 1 |
| Hitt, AR | 1 |
| Yakovlev, VV | 1 |
| Newell-Rogers, MK | 1 |
| Zawieja, DC | 1 |
| Meininger, CJ | 1 |
| Alpini, GD | 1 |
| Francis, H | 1 |
| Gashev, AA | 1 |
1 other study available for loratadine and Metabolic Syndrome
| Article | Year |
|---|---|
Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.
Topics: Adipose Tissue; Animals; Fatty Liver; Insulin Resistance; Lipids; Loratadine; Lymphatic Vessels; Mal | 2019 |